Candida infections in paediatrics: Results from a prospective single-centre study in a tertiary care children's hospital

Mycoses

Volumn 60, Issue 2, 2017, Pages 118-123

  Mesini, Alessio ^a   Bandettini, Roberto ^b   Caviglia, Ilaria ^b   Fioredda, Francesca ^b   Amoroso, Loredana ^b   Faraci, Maura ^b   Mattioli, Girolamo ^b   Piaggio, Giorgio ^b   Risso, Francesco M ^b   Moscatelli, Andrea ^b   Loy, Anna ^b   Castagnola, Elio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Candida; invasive fungal disease; paediatrics; prospective single centre study; urinary tract infection

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT;

ARTICLE; CANDIDEMIA; CANDIDIASIS; CHILD; CHILDHOOD CANCER; DISEASE PREDISPOSITION; FEMALE; FUNGEMIA; FUNGUS ISOLATION; HEALTH SURVEY; HUMAN; INVASIVE CANDIDIASIS; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEDIATRICS; PERITONITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINARY TRACT INFECTION; URINARY TRACT MALFORMATION; ADOLESCENT; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, INVASIVE; COMPLICATION; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEOPLASM; NEWBORN; RISK FACTOR; TERTIARY CARE CENTER; URINARY TRACT INFECTIONS;

ADOLESCENT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CANDIDIASIS, INVASIVE; CHILD; FEMALE; FUNGEMIA; HUMANS; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; NEOPLASMS; PERITONITIS; PROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; URINARY TRACT INFECTIONS;

EID: 85008497319     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12570     Document Type: Article

References (37)

1. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics. 2005;116:61–67.
2. Brissaud O, Guichoux J, Harambat J, Tandonnet O, Zaoutis T. Invasive fungal disease in PICU: epidemiology and risk factors. Ann Intensive Care. 2012;2:6.
3. Steinbach WJ, Roilides E, Berman D, et al. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J. 2012;31:1252–1257.
4. Tragiannidis A, Fegeler W, Rellensmann G, et al. Candidaemia in a European Paediatric University Hospital: a 10-year observational study. Clin Microbiol Infect. 2012;18:E27–E30.
5. Aliaga S, Clark RH, Laughon M, et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics. 2014;133:236–242.
6. Palazzi DL, Arrieta A, Castagnola E, et al. Candida speciation, antifungal treatment and adverse events in pediatric invasive candidiasis: results from 441 infections in a prospective, multi-national study. Pediatr Infect Dis J. 2014;33:1294–1296.
7. Shay AC, Miller LG. An estimate of the incidence of Candiduria among hospitalized patients in the United States. Infect Control Hosp Epidemiol. 2004;25:894–895.
8. Blot SI, Vandewoude KH, De Waele JJ. Candida peritonitis. Curr Opin Crit Care. 2007;13:195–199.
9. Singhi SC, Reddy TC, Chakrabarti A. Candidemia in a pediatric intensive careunit. Pediatr Crit Care Med. 2004;5:369–374.
10. Castagnola E, Cesaro S, Giacchino M, et al. Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J. 2006;25:634–639.
11. Barton M, O'Brien K, Robinson JL, et al. Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls. BMC Infect Dis. 2014;14:327.
12. Santolaya ME, Alvarado T, Queiroz-Telles F, et al. Active surveillance of candidemia in children from Latin America: a key requirement for improving disease outcome. Pediatr Infect Dis J. 2014;33:e40–e44.
13. Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J; Co-operative Group of the European Study Group on Nosocomial Infections. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect. 2001;7:523–531.
14. Manzoni P, Stolfi I, Pugni L, et al. Italian Task Force for the Study and Prevention of Neonatal Fungal Infections; Italian Society of Neonatology. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med. 2007;356:2483–2495.
15. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1–e50.
16. Hope WW, Castagnola E, Groll AH, et al. ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect. 2012;18(Suppl 7):38–52.
17. Swinscow TDV, revised by Campbell MJ. Statistic at Square One. Ninth Edition. BMJ Publishing Group 1997. http://www.bmj.com/about-bmj/resources-readers/publications/statistics-square-one. Accessed January 14, 2016.
18. Ota KV, McGowan KL. Declining incidence of candidemia in a tertiary inpatient pediatric population. J Clin Microbiol. 2012;50:1048–1050.
19. Fisher BT, Ross RK, Localio AR, Prasad PA, Zaoutis TE. Decreasing rates of invasive candidiasis in pediatric hospitals across the United States. Clin Infect Dis. 2014;58:74–77.
20. Kelly MS, Benjamin DK Jr, Smith PB. The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol. 2015;42:105–117, viii–ix.
21. Haupt R, Romanengo M, Fears T, Viscoli C, Castagnola E. Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution. Eur J Cancer. 2001;37:2413–2419.
22. Castagnola E, Caviglia I, Pistorio A, et al. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution. Eur J Cancer. 2005;41:1439–1445.
23. Castagnola E, Faraci M, Moroni C, et al. Invasive mycoses in children receiving hemopoietic SCT. Bone Marrow Transplant. 2008;41(Suppl 2):S107–S111.
24. Castagnola E, Bagnasco F, Bandettini R, et al. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study. Biol Blood Marrow Transplant. 2014;20:1068–1073.
25. Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis. 2010;51:e38–e45.
26. Nucci M, Queiroz-Telles F, Alvarado-Matute T, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS ONE. 2013;8:e59373.
27. Chan S, Baley ED, Hossain J, Di Pentima MC. Candida species bloodstream infections in hospitalised children: a 10-year experience. J Paediatr Child Health. 2015;51:857–860; quiz 861.
28. Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE. 2011;6:e24198.
29. Bassetti M, Merelli M, Righi E, et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol. 2013;51:4167–4172.
30. Sobel JD, Fisher JF, Kauffman CA, Newman CA. Candida urinary tract infections–epidemiology. Clin Infect Dis. 2011;52(Suppl 6):S433–S436.
31. Felton T, Troke PF, Hope WW. Tissue penetration of antifungal agents. Clin Microbiol Rev. 2014;27:68–88.
32. Grau S, Luque S, Echeverría-Esnal D, et al. Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp. Int J Antimicrob Agents. 2016;48:212–214.
33. Cornely OA, Gachot B, Akan H, et al. Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin Infect Dis. 2015;61:324–331. Erratum in: Donnelly, Peter J [corrected to Donnelly, J Peter]. Clin Infect Dis 2015;61:1635.
34. Bassetti M, Righi E, Ansaldi F, et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015;41:1601–1610.
35. Raaijmakers R, Schröder C, Monnens L, Cornelissen E, Warris A. Fungal peritonitis in children on peritoneal dialysis. Pediatr Nephrol. 2007;22:288–293.
36. Kim SH, Yoon YK, Kim MJ, Sohn JW. Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections. Clin Microbiol Infect. 2013;19:62–68.
37. Benjamin DK Jr, Stoll BJ, Gantz MG, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126:e865–e873.